Global Immunoassay Market Overview:
Global Immunoassay Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2026-2035, Considering the Base Year As 2025.
Global Immunoassay Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2026-2035, with base year as 2025. This research study of Immunoassay involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Immunoassay Market:
The Immunoassay Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Immunoassay Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Immunoassay Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Immunoassay market has been segmented into:
Radioimmunoassay
Enzyme Immunoassays
Fluoroimmnoassay
Chemiluminescence Immunoassay
Others
By Application, Immunoassay market has been segmented into:
Disease Diagnosis
Therapeutic Drug Monitoring
Drug Discovery
Clinical Chemistry
Hematology
Others
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Immunoassay market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Immunoassay market.
Top Key Players Covered in Immunoassay market are:
Abbott Laboratories Inc.
Becton Dickinson and Company
Danaher Corporation
Hologic Inc.
Qiagen NV
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Immunoassay Market Type
4.1 Immunoassay Market Snapshot and Growth Engine
4.2 Immunoassay Market Overview
4.3 Radioimmunoassay
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.3.3 Radioimmunoassay: Geographic Segmentation Analysis
4.4 Enzyme Immunoassays
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.4.3 Enzyme Immunoassays: Geographic Segmentation Analysis
4.5 Fluoroimmnoassay
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.5.3 Fluoroimmnoassay: Geographic Segmentation Analysis
4.6 Chemiluminescence Immunoassay
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.6.3 Chemiluminescence Immunoassay: Geographic Segmentation Analysis
4.7 Others
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
4.7.3 Others: Geographic Segmentation Analysis
Chapter 5: Immunoassay Market Application
5.1 Immunoassay Market Snapshot and Growth Engine
5.2 Immunoassay Market Overview
5.3 Disease Diagnosis
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.3.3 Disease Diagnosis: Geographic Segmentation Analysis
5.4 Therapeutic Drug Monitoring
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.4.3 Therapeutic Drug Monitoring: Geographic Segmentation Analysis
5.5 Drug Discovery
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.5.3 Drug Discovery: Geographic Segmentation Analysis
5.6 Clinical Chemistry
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.6.3 Clinical Chemistry: Geographic Segmentation Analysis
5.7 Hematology
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.7.3 Hematology: Geographic Segmentation Analysis
5.8 Others
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2026-2035F)
5.8.3 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Immunoassay Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 ABBOTT LABORATORIES INC.
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 BECTON DICKINSON AND COMPANY
6.4 DANAHER CORPORATION
6.5 HOLOGIC INC.
6.6 QIAGEN NV
Chapter 7: Global Immunoassay Market By Region
7.1 Overview
7.2. North America Immunoassay Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Radioimmunoassay
7.2.2.2 Enzyme Immunoassays
7.2.2.3 Fluoroimmnoassay
7.2.2.4 Chemiluminescence Immunoassay
7.2.2.5 Others
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Disease Diagnosis
7.2.3.2 Therapeutic Drug Monitoring
7.2.3.3 Drug Discovery
7.2.3.4 Clinical Chemistry
7.2.3.5 Hematology
7.2.3.6 Others
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Immunoassay Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Radioimmunoassay
7.3.2.2 Enzyme Immunoassays
7.3.2.3 Fluoroimmnoassay
7.3.2.4 Chemiluminescence Immunoassay
7.3.2.5 Others
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Disease Diagnosis
7.3.3.2 Therapeutic Drug Monitoring
7.3.3.3 Drug Discovery
7.3.3.4 Clinical Chemistry
7.3.3.5 Hematology
7.3.3.6 Others
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Immunoassay Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Radioimmunoassay
7.4.2.2 Enzyme Immunoassays
7.4.2.3 Fluoroimmnoassay
7.4.2.4 Chemiluminescence Immunoassay
7.4.2.5 Others
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Disease Diagnosis
7.4.3.2 Therapeutic Drug Monitoring
7.4.3.3 Drug Discovery
7.4.3.4 Clinical Chemistry
7.4.3.5 Hematology
7.4.3.6 Others
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Immunoassay Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Radioimmunoassay
7.5.2.2 Enzyme Immunoassays
7.5.2.3 Fluoroimmnoassay
7.5.2.4 Chemiluminescence Immunoassay
7.5.2.5 Others
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Disease Diagnosis
7.5.3.2 Therapeutic Drug Monitoring
7.5.3.3 Drug Discovery
7.5.3.4 Clinical Chemistry
7.5.3.5 Hematology
7.5.3.6 Others
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Immunoassay Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Radioimmunoassay
7.6.2.2 Enzyme Immunoassays
7.6.2.3 Fluoroimmnoassay
7.6.2.4 Chemiluminescence Immunoassay
7.6.2.5 Others
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Disease Diagnosis
7.6.3.2 Therapeutic Drug Monitoring
7.6.3.3 Drug Discovery
7.6.3.4 Clinical Chemistry
7.6.3.5 Hematology
7.6.3.6 Others
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Immunoassay Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Radioimmunoassay
7.7.2.2 Enzyme Immunoassays
7.7.2.3 Fluoroimmnoassay
7.7.2.4 Chemiluminescence Immunoassay
7.7.2.5 Others
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Disease Diagnosis
7.7.3.2 Therapeutic Drug Monitoring
7.7.3.3 Drug Discovery
7.7.3.4 Clinical Chemistry
7.7.3.5 Hematology
7.7.3.6 Others
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Immunoassay Scope:
|
Report Data
|
Immunoassay Market
|
|
Immunoassay Market Size in 2025
|
USD XX million
|
|
Immunoassay CAGR 2025 - 2032
|
XX%
|
|
Immunoassay Base Year
|
2024
|
|
Immunoassay Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Abbott Laboratories Inc., Becton Dickinson and Company, Danaher Corporation, Hologic Inc., Qiagen NV.
|
|
Key Segments
|
By Type
Radioimmunoassay
Enzyme Immunoassays
Fluoroimmnoassay
Chemiluminescence Immunoassay
Others
By Applications
Disease Diagnosis
Therapeutic Drug Monitoring
Drug Discovery
Clinical Chemistry
Hematology
Others
|
